Life Sciences Night at the Opera 2022

Community
Life Sciences Night at the Opera Save the Date Short Twitter Post

Join us in supporting the San Diego Opera’s Life Sciences Night program! The 2022 Life Sciences Night at the Opera is an elegant event that brings together the San Diego’s Life Sciences community to enjoy world-class opera and high-level networking. Notable guests representing San Diego’s vibrant ecosystem will gather for a Pre-Opera Reception, followed by San Diego Opera’s production of Gounod’s operatic masterpiece, Roméo et Juliette, with VIP Hospitality during intermission.

Theater guests are required to wear face coverings throughout the performance. If you require socially distanced seating, please call Erin Oleno directly at (619) 533-7020.

AT THE OPERA
LIFE SCIENCES NIGHT
March 29, 2022 | 5:30 – 7:30PM
The Westin San Diego Gaslamp Quarter
910 Broadway Circle, San Diego

EVENING SCHEDULE
NETWORKING EVENT: 5:30 to 7:00PM
Westin Gaslamp, 910 Broadway Circle
Hotel Valet or Self-Park at 225 Broadway Parking Garage

OPERA PERFORMANCE: 7:30PM
SAN DIEGO CIVIC THEATRE
Roméo et Juliette by Charles Gounod

VIP INTERMISSION HOSPITALITY
CIVIC THEATRE CONCOURSE, RECEPTION TENT
Network again during the opera’s intermission while enjoying champagne and desserts.

GUEST SPEAKER
Dr. Erica Ollman Saphire,
President and CEO, La Jolla Institute for Immunology

Dr. Saphire is a professor in LJI’s Center for Infectious Disease and Vaccine Research and the Director of the Coronavirus Immunotherapy Consortium (CoVIC), which united academics, non-profits, small and large biotechs, and major corporations from around the globe to address the urgent need of identifying the most efficacious antibody therapeutics to prevent and treat COVID-19.

Throughout her career, Dr. Saphire had her sights firmly trained on the global threat of highly infectious diseases. Before CoVIC, she galvanized the Viral Hemorrhagic Fever Immunotherapeutic Consortium (VIC), a multidisciplinary, five-continent collaboration of former competitors that together resolved the gulf between results obtained in the lab and treatments needed in the field against emerging viral threats such as Ebola and Lassa. In her own lab, Dr. Saphire studies the threedimensional structures that drive immune recognition and protection. Her research reveals where viruses are vulnerable, how a successful immune response can be mounted, and draws the blueprints for better vaccines and treatments.

Dr. Saphire received an undergraduate degree from Rice University with a dual major in Biochemistry and in Cell Biology and Evolutionary Biology. She received her Ph.D. degree in 2000 from Scripps Research. After postdoctoral work at Scripps Research, Dr. Saphire joined the faculty at Scripps Research as an Assistant Professor in 2003. Dr. Saphire was steadily promoted there, becoming a full Professor in 2012. In 2019, she joined LJI.

Dr. Saphire’s work has been recognized at the White House with the Presidential Early Career Award in Science and Engineering, with the Gallo award in Scientific Leadership from the Global Virus Network, and young investigator awards from the International Congress of Antiviral Research, the American Society for Microbiology, and the MRC Centre for Virus Research in the United Kingdom. She has been awarded a Fulbright Global Scholar fellowship from the United States Department of State and a Mercator Fellowship from Deutsche Forschungsgemeinschaft, to develop international collaborations using cryoelectron microscopy to further global health, and was the 2021 Scientist of the Year of the ARCS Foundation.

Subscribe to WXPress

Receive our newsletter and information on upcoming events.